203 related articles for article (PubMed ID: 17547476)
1. Imidapril: a review of its use in essential hypertension, Type 1 diabetic nephropathy and chronic heart failure.
Robinson DM; Curran MP; Lyseng-Williamson KA
Drugs; 2007; 67(9):1359-78. PubMed ID: 17547476
[TBL] [Abstract][Full Text] [Related]
2. Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor.
Hosoya K; Ishimitsu T
Cardiovasc Drug Rev; 2002; 20(2):93-110. PubMed ID: 12177688
[TBL] [Abstract][Full Text] [Related]
3. Imidapril in heart failure.
Dolezal T
J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):146-54. PubMed ID: 17094051
[TBL] [Abstract][Full Text] [Related]
4. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the incidence of imidapril and enalapril induced cough.
Boonyapisit W; Tresukosol D
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S48-53. PubMed ID: 20364557
[TBL] [Abstract][Full Text] [Related]
6. Cough-challenge trial with a new angiotensin-converting enzyme inhibitor, imidapril.
Shionoiri H; Takasaki I; Minamisawa K; Ueda S; Kihara M; Shindo K; Hiroto S; Sugimoto K; Himeno H; Naruse M; Nagamochi I; Yasuda G
J Clin Pharmacol; 1998 May; 38(5):442-6. PubMed ID: 9602958
[TBL] [Abstract][Full Text] [Related]
7. Clearance of imidapril, an Angiotensin-converting enzyme inhibitor, during hemodialysis in hypertensive renal failure patients: comparison with quinapril and enalapril.
Tsuruoka S; Kitoh Y; Kawaguchi A; Sugimoto K; Hayasaka T; Saito T; Fujimura A
J Clin Pharmacol; 2007 Feb; 47(2):259-63. PubMed ID: 17244777
[TBL] [Abstract][Full Text] [Related]
8. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice.
Katoh M; Ohmachi Y; Kurosawa Y; Yoneda H; Tanaka N; Narita H
Eur J Pharmacol; 2000 Jun; 398(3):381-7. PubMed ID: 10862828
[TBL] [Abstract][Full Text] [Related]
9. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
10. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
[TBL] [Abstract][Full Text] [Related]
11. Imidapril: will fewer adverse events translate into better long-term outcomes?
Richart T; Staessen JA; Birkenhäger WH
Drugs; 2007; 67(9):1379-82. PubMed ID: 17547477
[No Abstract] [Full Text] [Related]
12. Difference in the incidence of cough induced by angiotensin converting enzyme inhibitors: a comparative study using imidapril hydrochloride and enalapril maleate.
Saruta T; Arakawa K; Iimura O; Abe K; Matsuoka H; Nakano T; Nakagawa M; Ogihara T; Kajiyama G; Hiwada K; Fujishima M; Nakajima M
Hypertens Res; 1999 Sep; 22(3):197-202. PubMed ID: 10515442
[TBL] [Abstract][Full Text] [Related]
13. Combination of half doses of angiotensin type 1 receptor antagonist and angiotensin-converting enzyme inhibitor in diabetic nephropathy.
Fujisawa T; Ikegami H; Ono M; Nishino M; Noso S; Kawabata Y; Ogihara T
Am J Hypertens; 2005 Jan; 18(1):13-7. PubMed ID: 15691611
[TBL] [Abstract][Full Text] [Related]
14. A 24-week dose-titration study of the angiotensin-converting enzyme inhibitor imidapril in the treatment of mild-to-moderate essential hypertension in the elderly.
Dews I; VandenBurg M
J Int Med Res; 2001; 29(2):100-7. PubMed ID: 11393342
[TBL] [Abstract][Full Text] [Related]
15. High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril.
van Veldhuisen DJ; Genth-Zotz S; Brouwer J; Boomsma F; Netzer T; Man In 'T Veld AJ; Pinto YM; Lie KI; Crijns HJ
J Am Coll Cardiol; 1998 Dec; 32(7):1811-8. PubMed ID: 9857856
[TBL] [Abstract][Full Text] [Related]
16. Improvement of organ damage by a non-depressor dose of imidapril in diabetic spontaneously hypertensive rats.
Tomita N; Yamasaki K; Izawa K; Kunugiza Y; Osako MK; Ogihara T; Morishita R
Int J Mol Med; 2007 Apr; 19(4):571-9. PubMed ID: 17334632
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of imidapril in congestive heart failure in dogs: results of the EFFIC study.
Besche B; Chetboul V; Lachaud Lefay MP; Grandemange E
J Small Anim Pract; 2007 May; 48(5):265-70. PubMed ID: 17472664
[TBL] [Abstract][Full Text] [Related]
18. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control.
Saruta T; Omae T; Kuramochi M; Iimura O; Yoshinaga K; Abe K; Ishii M; Watanabe T; Takeda T; Ito K
J Hypertens Suppl; 1995 Sep; 13(3):523-30. PubMed ID: 8592249
[TBL] [Abstract][Full Text] [Related]
19. Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM).
Katayama S; Kikkawa R; Isogai S; Sasaki N; Matsuura N; Tajima N; Urakami T; Uchigata Y; Ohashi Y
Diabetes Res Clin Pract; 2002 Feb; 55(2):113-21. PubMed ID: 11796177
[TBL] [Abstract][Full Text] [Related]
20. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
